Interaction of novel proteins, centrin4 and protein of centriole in Leishmania parasite and their effects on the parasite growth.


Journal

Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731

Informations de publication

Date de publication:
03 2023
Historique:
received: 24 07 2022
revised: 07 12 2022
accepted: 14 12 2022
pubmed: 10 1 2023
medline: 14 2 2023
entrez: 9 1 2023
Statut: ppublish

Résumé

Centrins are cytoskeletal proteins associated with the centrosomes or basal bodies in the eukaryotes. We previously reported the involvement of Centrin 1-3 proteins in cell division in the protozoan parasites Leishmania donovani and Trypanosoma brucei. Centrin4 and 5, unique to such parasites, had never been characterized in Leishmania parasite. In the current study, we addressed the function of centrin4 (LdCen4) in Leishmania. By dominant-negative study, the episomal expression of C-terminal truncated LdCen4 in the parasite reduced the parasite growth. LdCen4 double allele gene deletion by either homologous recombination or CRISPR-Cas9 was not successful in L. donovani. However, CRISPR-Cas9-based deletion of the homologous gene was possible in L. mexicana, which attenuated the parasite growth in vitro, but not ex vivo in the macrophages. LdCen4 also interacts with endogenous and overexpressed LdPOC protein, a homolog of centrin reacting human POC (protein of centriole) in a calcium sensitive manner. LdCen4 and LdPOC binding has also been confirmed through in silico analysis by protein structural docking and validated by co-immunoprecipitation. By immunofluorescence studies, we found that both the proteins share a common localization at the basal bodies. Thus, for the first time, this article describes novel centrin4 and its binding protein in the protozoan parasites.

Identifiants

pubmed: 36623775
pii: S0167-4889(22)00208-7
doi: 10.1016/j.bbamcr.2022.119416
pii:
doi:

Substances chimiques

Calcium-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

119416

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest to declare.

Auteurs

Kavita Vats (K)

Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India; Department of Bio & Nano Technology, Bio & Nano Technology Centre, Guru Jambheshwar University of Science and Technology, Hisar 125001, India; MiVEGEC, University of Montpellier, CNRS, IRD, Academic Hospital (CHU) of Montpellier, Montpellier 34295, France.

Rati Tandon (R)

Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.

Mirza A Beg (MA)

Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.

Rosa M Corrales (RM)

MiVEGEC, University of Montpellier, CNRS, IRD, Academic Hospital (CHU) of Montpellier, Montpellier 34295, France.

Akila Yagoubat (A)

MiVEGEC, University of Montpellier, CNRS, IRD, Academic Hospital (CHU) of Montpellier, Montpellier 34295, France.

Enam Reyaz (E)

Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.

Tasaduq H Wani (TH)

Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.

Mirza S Baig (MS)

Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.

Ashok Chaudhury (A)

Department of Bio & Nano Technology, Bio & Nano Technology Centre, Guru Jambheshwar University of Science and Technology, Hisar 125001, India.

Anuja Krishnan (A)

Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.

Niti Puri (N)

School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.

Poonam Salotra (P)

ICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi 110029, India.

Yvon Sterkers (Y)

MiVEGEC, University of Montpellier, CNRS, IRD, Academic Hospital (CHU) of Montpellier, Montpellier 34295, France.

Angamuthu Selvapandiyan (A)

Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India. Electronic address: selvapandiyan@jamiahamdard.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH